United States · FDA National Drug Code directory

Triamterene and Hydrochlorothiazide

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
50090-1270_2b8f9bb4-9da2-4267-abc3-c2b76bf6d521
Product NDC
50090-1270
Form
TABLET
Composition / generic term
Triamterene and Hydrochlorothiazide
Labeler
A-S Medication Solutions
Marketing category
ANDA
Marketing start / end (source format)
19930923 / 20280630

Source-listed ingredients

  • TRIAMTERENE — 37.5 mg/1
  • HYDROCHLOROTHIAZIDE — 25 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 TABLET in 1 BOTTLE (50090-1270-0) · 50090-1270-0
  • 100 TABLET in 1 BOTTLE (50090-1270-1) · 50090-1270-1
  • 90 TABLET in 1 BOTTLE (50090-1270-2) · 50090-1270-2

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →